Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations

被引:48
|
作者
Hagenah, J. M. [1 ]
Becker, B. [1 ]
Brueggemann, N. [1 ]
Djarmati, A. [1 ,2 ]
Lohmann, K. [1 ,2 ]
Sprenger, A. [1 ]
Klein, C. [1 ,2 ]
Seidel, G. [1 ]
机构
[1] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany
[2] Med Univ Lubeck, Dept Human Genet, D-23538 Lubeck, Germany
来源
关键词
D O I
10.1136/jnnp.2007.142174
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To investigate substantia nigra (SN) echo-genicity in members of a family with homozygous and heterozygous PTEN induced kinase (PINK1) mutations with or without signs of Parkinson's disease (PD). Methods: Transcranial sonography (TCS) was used to investigate 20 members of a family with PINK1 mutations, including four homozygous and 11 heterozygous mutation carriers and five individuals with no mutation. For comparison, a healthy control group of 18 subjects without a positive family history of PD (control group) and a healthy control group of 15 subjects with a positive family history of sporadic PD (relative group) were investigated. For statistical analysis, the larger area of the two SNs echogenicity (aSNmax) of each individual was selected. Results: A significantly increased aSNmax was found for all subgroups compared with the control group. The group of homozygous carriers of a PINK1 mutation had a significantly increased aSNmax compared with all of the other subgroups, except the group of heterozygous mutation carriers. Conclusions: These findings in carriers of a PINK1 mutation are comparable with those in carriers of Parkin mutations and non-genetic PD. The increased aSNmax in family members without a mutation suggests an additional contributing factor independent of the PINK1 mutation that may also play a role in relatives of patients with sporadic PD.
引用
收藏
页码:1071 / 1074
页数:4
相关论文
共 50 条
  • [1] Clinical spectrum of PINK1 mutations and evidence for a role of heterozygous mutations in a large family
    Klein, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 310 - 310
  • [2] Clinical spectrum of homozygous and heterozygous PINK1 mutations in a large German family with Parkinson disease : Role of a single hit?
    Hedrich, Katja
    Hagenah, Johann
    Djarmati, Ana
    Hiller, Anja
    Lohnau, Thora
    Lasek, Kathrin
    Gruenewald, Anne
    Hilker, Ruediger
    Steinlechner, Susanne
    Boston, Heather
    Kock, Norman
    Schneider-Gold, Christiane
    Kress, Wolfram
    Siebner, Hartwig
    Binkofski, Ferdinand
    Lencer, Rebekka
    Muenchau, Alexander
    Klein, Christine
    ARCHIVES OF NEUROLOGY, 2006, 63 (06) : 833 - 838
  • [3] Detection of increased echogenicity in the substantia nigra in a large family with homo -: and heterozygous PINK1 mutations
    Hagenah, J. M.
    Seidel, G.
    Brueggemann, N.
    Djarmati, A.
    Lohmann, K.
    Sprenger, A.
    Klein, C.
    MOVEMENT DISORDERS, 2007, 22 : S177 - S178
  • [4] Pink1 heterozygous mutations in familial Parkinson's disease
    Hayashida, A.
    Li, Y.
    Yoshino, H.
    Nakahara, T.
    Yoritaka, A.
    Nagara, Y.
    Sakiyama, Y.
    Kusaka, H.
    Takiyama, Y.
    Morimoto, N.
    Uchino, A.
    Fujimoto, T.
    Sekijima, Y.
    Tomimoto, H.
    Tsuruta, K.
    Hattori, Y.
    Kashihara, K.
    Funayama, M.
    Nishioka, K.
    Hattori, N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 161 - +
  • [5] Heterozygous PINK1 mutations:: A susceptibility factor for Parkinson disease?
    Djarmati, Ana
    Hedrich, Katja
    Svetel, Marina
    Lohnau, Thora
    Schwinger, Eberhard
    Romac, Stanka
    Pramstaller, Peter P.
    Kostic, Vladimir
    Klein, Christine
    MOVEMENT DISORDERS, 2006, 21 (09) : 1526 - 1530
  • [6] A heterozygous effect for PINK1 mutations in Parkinson's disease?
    Abou-Sleiman, Patrick M.
    Muqit, Miratul M. K.
    McDonald, Neil Q.
    Yang, Yan Xiang
    Gandhi, Sonia
    Healy, Daniel G.
    Harvey, Kirsten
    Harvey, Robert J.
    Deas, Emma
    Hatia, Kailash
    Quinn, Niall
    Lees, Andrew
    Latchman, David S.
    Wood, Nicholas W.
    ANNALS OF NEUROLOGY, 2006, 60 (04) : 414 - 419
  • [7] Heterozygous PINK1 mutations are a significant risk factor in sporadic PD
    Abou-Sleiman, PM
    Muqit, MMK
    Gandhi, S
    Harvey, K
    Harvey, RJ
    Bhatia, K
    MOVEMENT DISORDERS, 2006, 21 : S52 - S52
  • [8] Heterozygous mutations in PINK1 kinase domain exert a gene dosage effect
    Angeles, D.
    Refai, F.
    Siddique, M.
    Yap, K.
    Ho, P.
    Fook-Chong, S.
    Zhao, Y.
    Tan, E. -K.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S171 - S171
  • [9] PINK1 mutations and parkinsonism
    Ishihara-Paul, L.
    Hulihan, M. M.
    Kachergus, J.
    Upmanyu, R.
    Warren, L.
    Amouri, R.
    Elango, R.
    Prinjha, R. K.
    Soto, A.
    Kefi, M.
    Zouari, M.
    Sassi, S. B.
    Yahmed, S. B.
    El Euch-Fayeche, G.
    Matthews, P. M.
    Middleton, L. T.
    Gibson, R. A.
    Hentati, F.
    Farrer, M. J.
    NEUROLOGY, 2008, 71 (12) : 896 - 902
  • [10] Genetic mutations and functions of PINK1
    Kawajiri, Sumihiro
    Saiki, Shinji
    Sato, Shigeto
    Hattori, Nobutaka
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (10) : 573 - 580